Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$6.94 - $14.22 $6.88 Million - $14.1 Million
-991,598 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$7.99 - $37.6 $28,404 - $133,668
3,555 Added 0.36%
991,598 $7.95 Million
Q3 2019

Nov 14, 2019

BUY
$19.17 - $27.4 $3.14 Million - $4.48 Million
163,649 Added 19.85%
988,043 $20.3 Million
Q2 2019

Aug 14, 2019

BUY
$22.93 - $42.84 $7.67 Million - $14.3 Million
334,329 Added 68.22%
824,394 $21.5 Million
Q1 2019

May 15, 2019

BUY
$32.69 - $47.91 $1.07 Million - $1.58 Million
32,883 Added 7.19%
490,065 $19 Million
Q4 2018

Feb 14, 2019

BUY
$37.1 - $50.11 $509,086 - $687,609
13,722 Added 3.09%
457,182 $19.2 Million
Q3 2018

Nov 14, 2018

SELL
$36.35 - $55.2 $419,442 - $636,952
-11,539 Reduced 2.54%
443,460 $22.2 Million
Q2 2018

Aug 14, 2018

BUY
$33.85 - $50.65 $2.24 Million - $3.36 Million
66,280 Added 17.05%
454,999 $17.4 Million
Q1 2018

May 15, 2018

SELL
$32.45 - $54.7 $909,411 - $1.53 Million
-28,025 Reduced 6.72%
388,719 $15.6 Million
Q4 2017

Feb 14, 2018

SELL
$21.8 - $39.35 $736,316 - $1.33 Million
-33,776 Reduced 7.5%
416,744 $14.6 Million
Q3 2017

Nov 14, 2017

BUY
$16.4 - $25.05 $7.39 Million - $11.3 Million
450,520
450,520 $9.8 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.